The importance of heterogeneity on the management of vector borne diseases

February 1, 2018, Liverpool School of Tropical Medicine

Researchers at LSTM have been working with colleagues in the NTD modelling consortium to look at the role that heterogeneity in mosquito biting plays within the transmission of disease and what impact vector control has on that heterogeneity.

While it is well known that some individuals within the same community may be exposed to a different number of , very few studies have been carried out to measure the causes of that , or variance, to understand its impact on the control of vector-borne diseases in a way that is relevant to decision making.

In a paper published today in the journal Proceedings of the Royal Society B the team, including LSTM's Dr. Lisa Reimer, uses modelling and surveillance data to investigate the relationship between spatial and individual heterogeneity in the context of , finding that both measures are qualitatively different with profoundly different policy implications.

Vector borne disease control often relies on universal distribution of interventions, such as long-lasting insecticide treated bednets for malaria and mass drug administration for filariasis. These interventions are distributed in a heterogeneous environment—where humans experience different levels of exposure, due to both individual and spatial factors. Dr. Reimer said: "In this study, we explored the links between heterogeneous mosquito bite exposure and filariasis infection and how relationships change with the distribution of bednets. We concluded that the sources of heterogeneity within a transmission system have different implications for the success of mass drug administration (MDA) in achieving elimination."

Using infection and mosquito bite data for five villages in Papua New Guinea the team measured biting characteristics to model the impact of bednets on disease control and combined this with geospatial modelling. They found that when individual heterogeneity is high, a very high coverage of MDA would be needed to ensure the small group of individuals contributing to transmission are treated, and targeted treatment may be necessary. When spatial heterogeneity is high, different villages may have very different prevalence and the use of sentinel sites to determine regional elimination will not give an accurate picture.

"Our research in Papua New Guinea shows that the distribution of bednets increased heterogeneity in exposure," continued Dr. Reimer, "which could potentially lengthen the number of rounds of MDA required. However, we also found that the introduction of bednets reduced nightly biting enough to offset this effect. What is clear following this research is the importance of understanding sources of heterogeneity to the control and elimination of ."

Explore further: Insecticide-treated bed nets critical to global elimination of filariasis

More information: Michael A. Irvine et al. Understanding heterogeneities in mosquito-bite exposure and infection distributions for the elimination of lymphatic filariasis, Proceedings of the Royal Society B: Biological Sciences (2018). DOI: 10.1098/rspb.2017.2253

Related Stories

Insecticide-treated bed nets critical to global elimination of filariasis

August 21, 2013
An international team of scientists have demonstrated that a simple, low-cost intervention holds the potential to eradicate a debilitating tropical disease that threatens nearly 1.4 billion people in more than six dozen countries.

Malaria—should we abandon insecticide-treated bednets?

July 12, 2016
In Africa, some malaria-carrying mosquitoes have found ways to survive exposure to insecticides. This means that bednets treated with these chemicals may become less effective at preventing malaria. A new study we've published ...

Researchers decipher molecular basis of resistance in the African vector Anopheles funestus

November 2, 2015
Researchers at LSTM have shown the means by which one of the major species of mosquito responsible for transmitting malaria in Africa is becoming resistant to the insecticides used to treat the bednets which protect people ...

A new way to thwart disease-spreading mosquitoes

January 29, 2018
(HealthDay)—It sounds like science fiction, but researchers say they have taken the first step toward creating female mosquitoes that don't bite and spread disease.

Factor that doubles the risk of death from breast cancer identified

January 19, 2018
Researchers at Karolinska Institutet in Sweden have discovered that the risk of death from breast cancer is twice as high for patients with high heterogeneity of the oestrogen receptor within the same tumour as compared to ...

Recommended for you

Scientists gain new insight on how antibodies interact with widespread respiratory virus

February 22, 2018
Scientists have found and characterized the activity of four antibodies produced by the human immune system that target an important protein found in respiratory syncytial virus (RSV), according to new research published ...

Study reveals how kidney disease happens

February 22, 2018
Monash researchers have solved a mystery, revealing how certain immune cells work together to instigate autoimmune kidney disease.

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.